| View |
|
DRP-13950-01
|
Ceftriaxone (as sodium)
|
Ceftriaking
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Third-generation Cephalosporin)
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
24 April 2024
|
24 May 2028
|
| View |
|
DRP-13983-06
|
Apixaban
|
Fixulate
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 April 2024
|
31 May 2028
|
| View |
|
DRP-13984-05
|
Apixaban
|
Fixulate
|
2.5 mg
|
Film-Coated Tablet
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 April 2024
|
31 May 2028
|
| View |
|
DRP-14007-01
|
Ceftriaxone (as sodium)
|
Axonefree
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
26 April 2024
|
05 June 2028
|
| View |
|
DRP-14029-01
|
Pantoprazole (as sodium sesquihydrate) + Domperidone (as maleate)
|
None
|
40 mg / 30 mg
|
Modified Release Capsule
|
Proton Pump Inhibitor/Propulsive
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
24 April 2024
|
07 June 2028
|
| View |
|
DRP-14046-03
|
Cetirizine (as hydrochloride)
|
Sherizine
|
10 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine Derivative)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
18 April 2024
|
08 June 2028
|
| View |
|
DRP-14076-01
|
Co-Amoxiclav
|
None
|
625 mg
|
Film - Coated Tablet
|
Antibacterial (Penicillin / Beta-Lactamase Inhibitor)
|
Sun Pharmaceutical Industries Limited
|
India
|
CLIDP Conversion
|
10 April 2024
|
14 June 2028
|
| View |
|
DRP-14088-06
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
None
|
3 mg /1 mg (0.3% / 0.1% w/v) per mL
|
Sterile Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
07 April 2024
|
20 June 2028
|
| View |
|
DRP-14088-07
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
Dikshamin
|
3 mg/1 mg (0.3%/0.1% w/v) per mL
|
Sterile Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside)/Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
24 April 2024
|
20 June 2028
|
| View |
|
DRP-14096-03
|
Clindamycin (as Phosphate)
|
None
|
150 mg/mL
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
07 April 2024
|
20 June 2028
|
| View |
|
DRP-14138-02
|
Azithromycin (as dihydrate)
|
Rozenta
|
200 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial (Macrolide)
|
S Kant Healthcare Limited
|
India
|
CLIDP Conversion
|
24 April 2024
|
30 June 2028
|
| View |
|
DRP-14198-01
|
Febuxostat
|
Urixa
|
40 mg
|
Film-Coated Tablet
|
Anti-gout (Preparation Inhibiting Uric Acid Production)
|
Gracure Pharmaceutical Ltd.
|
India
|
CLIDP Conversion
|
15 April 2024
|
18 July 2028
|
| View |
|
DRP-14203-02
|
Clindamycin (as phosphate)
|
None
|
150mg/mL (300mg/2mL)
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
Maxitech Pharma (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
30 April 2024
|
20 July 2028
|
| View |
|
DRP-14255-01
|
Metformin Hydrochloride
|
Nimrof
|
850 mg
|
Film-Coated Tablet
|
Blood Glucose-Lowering Drug (Biguanide)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
24 April 2024
|
04 August 2025
|
| View |
|
DRP-14255-02
|
Metformin Hydrochloride
|
Rafor
|
850 mg
|
Film-Coated Tablet
|
Blood Glucose-Lowering Drug (Biguanide)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
24 April 2024
|
04 August 2025
|
| View |
|
DRP-14286-01
|
Levodropropizine
|
Cofzol CS
|
30 mg / 5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
10 April 2024
|
11 August 2028
|
| View |
|
DRP-14323-01
|
Tacrolimus
|
Acrolim 0.1
|
1 mg/g (0.1% w/w)
|
Topical Ointment
|
Agents for Dermatitis
|
The Madras Pharmaceuticals
|
India
|
CLIDP Conversion
|
10 April 2024
|
17 August 2028
|
| View |
|
DRP-14343-01
|
Fusidic Acid
|
Biofusid
|
20 mg/g (2% w/w)
|
Topical Cream
|
Antibiotic (for topical use)
|
Lincoln Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
15 April 2024
|
23 August 2028
|
| View |
|
DRP-14354-02
|
Salbutamol (as sulfate)
|
Salbfixx
|
100 mcg/actuation
|
Pressurized Metered-Dose Inhaler
|
Selective Beta-2-Adrenoreceptor Agonist
|
Jewim Pharmaceutical (Shangdong) Co., Ltd.
|
China
|
CLIDP Conversion
|
10 April 2024
|
24 August 2028
|
| View |
|
DRP-14484-04
|
Potassium citrate
|
Acitrate Plus
|
1.620 g (15 mEq)
|
Extended-Release Tablet
|
Antiurolithic
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
25 April 2024
|
12 September 2028
|